Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLORQUINITAU: 32 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
32
Total FAERS Reports
0
Deaths Reported
2
Hospitalizations
32
As Primary/Secondary Suspect

First Report: 20230216 · Latest Report: 20231120

What Are the Most Common FLORQUINITAU Side Effects?

#1 Most Reported
Amyloid related imaging abnormality-oedema/effusion
19 reports (59.4%)
#2 Most Reported
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits
19 reports (59.4%)
#3 Most Reported
Superficial siderosis of central nervous system
5 reports (15.6%)

All FLORQUINITAU Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits 19 59.4% 0 0
Amyloid related imaging abnormality-oedema/effusion 19 59.4% 0 1
Superficial siderosis of central nervous system 5 15.6% 0 1

Who Reports FLORQUINITAU Side Effects? Age & Gender Data

Gender: 37.5% female, 62.5% male. Average age: 74.5 years. Most reports from: US. View detailed demographics →

Is FLORQUINITAU Getting Safer? Reports by Year

YearReportsDeathsHosp.
2023 32 0 2

View full timeline →

What Is FLORQUINITAU Used For?

IndicationReports
Positron emission tomogram 32

Official FDA Label for FLORQUINITAU

Official prescribing information from the FDA-approved drug label.